Friday, July 10, 2026

pharma · Colorectal Neoplasms · Borderline Resectable Pancreatic Adenocarcinoma

Zhejiang Rongyao Biotech

News and analysis for Zhejiang Rongyao Biotech on NovaPharmaNews — regulatory, clinical, and market coverage.

CN HQ
1999 Founded
5 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Founded
1999
Employees
5
Programs
2
Drugs
3
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Zhejiang Rongyao Biotech — regulatory, clinical, and market coverage.

News and analysis for Zhejiang Rongyao Biotech on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Zhejiang Rongyao Biotech yet.

Back to company overview →